NCT04187755View on ClinicalTrials.gov

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Neutropenia, FebrileLeukemiaPediatric CancerAntibiotic Reaction
Interventions
DRUG

Ceftazidime Injection

Ceftazidime was administered intravenously with usual standard dose for serious infection (50 mg/kgBW/dose, 6 hourly)

DRUG

Cefepime Injection

Cefepime was administered intravenously with usual standard dose for serious infection (50 mg/kgBW/dose, 8 hourly)

Trial Locations (1)

Unknown

Cipto Mangunkusumo General Hospital, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT04187755 - Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever | Biotech Hunter | Biotech Hunter